Search
for
Sort by
Research 301–330 of 1000+
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- 691 Topical curcumin promotes induction of the murine hair cycle
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- Alopecia – New building blocks
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Hair Follicle Reconstruction and Stem Cells
- Alopecia Areata Barbae in a Nutshell
- Alopecia areata
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Baricitinib: A Review in Severe Alopecia Areata
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Alopecia universalis. Partial response to tofacitinib